Retension Pharmaceuticals, Inc. (RTSN)
10.69
-0.03
(-0.28%)
USD |
NASDAQ |
Nov 06, 10:17
Retension Pharmaceuticals EPS Diluted (Quarterly) : -0.5292 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.5292 |
| March 31, 2026 | -0.4256 |
| Date | Value |
|---|---|
| June 30, 2025 | -0.156 |
| March 31, 2025 | -0.0833 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AbbVie, Inc. | 2.373 |
| Abeona Therapeutics, Inc. | -0.3539 |
| America Great Health | 0.00 |
| Acumen Pharmaceuticals, Inc. | -0.3508 |
| Aardvark Therapeutics, Inc. | -0.6586 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.171M |
| Total Expenses (Quarterly) | 4.171M |
| Enterprise Value | 99.17M |
| Earnings Yield | -11.17% |
| Normalized Earnings Yield | -11.17 |